BridgeMD
Compares treatment options for Cancer
Official title Randomized Controlled Trial of Remote Symptoms Monitoring With Resilience PRO Compared to Care As Usual Only
ClinicalTrials.gov ID: NCT06867705
What this study is testing
- What it's testing
- The goal of this clinical trial is to learn if Resilience PRO, a digital solution performing remote symptoms monitoring, can improve the quality of life of patients with a diagnosis of cancer receiving systemic anticancer treatment. The main question it aims to answer is: \- Do patients with a diagnosis of cancer receiving systemic anticancer therapy and using Resilience PRO have an improved quality of life?
- Phase 3: a large, late-stage study
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age: Adults ≥ 18 years.
- Informed Consent: Patient giving signed informed consent to participate in the RC - 102 clinical study.
- Diagnosis: Patients with cancer at any stage.
- Systemic Treatment
- Remote Monitoring Eligibility: Access to a smartphone
You likely can't join if
- Age: Patients under 18 years of age.
- Life Expectancy: Patients with a life expectancy of less than 6 months as estimated by the treating physician.
- Concurrent remote monitoring
- HSCT or CAR-T Therapy
- Cognitive Impairment
- Pregnancy or breastfeeding
See the full eligibility criteria
- Age: Adults ≥ 18 years.
- Informed Consent: Patient giving signed informed consent to participate in the RC - 102 clinical study.
- Diagnosis: Patients with cancer at any stage.
- Systemic Treatment
- Remote Monitoring Eligibility: Access to a smartphone
- Language: Ability to understand and communicate in the language(s) in which the trial is conducted.
- Age: Patients under 18 years of age.
- Life Expectancy: Patients with a life expectancy of less than 6 months as estimated by the treating physician.
- Concurrent remote monitoring
- HSCT or CAR-T Therapy
- Cognitive Impairment
- Pregnancy or breastfeeding
- Subject under administrative or judicial control
The study team makes the final eligibility decision.
Where it's taking place
- Aix-en-Provence, France
- Aurillac, France
- Bayonne, France
- Caen, France
- Clermont-Ferrand, France
- La Tronche, France
- Lille, France
- Lyon, France
- Marseille, France
- Nantes, France
- Nice, France
- Nîmes, France
- Paris, France
- Quimper, France
- Saint-Etienne, France
- Saint-Nazaire, France
- Saint-Pierre, France
- Soyaux, France
- Toulon, France
- Toulouse, France
+ 12 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Aix-en-Provence, France; Aurillac, France; Bayonne, France; Caen, France; Clermont-Ferrand, France; La Tronche, France and 26 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.